Exact Sciences (EXAS) Merger with Abbott Moving Forward After Shareholder Approval
Exact Sciences Corp. (NASDAQ:EXAS) is one of 15 stocks with the biggest hedge fund momentum, after gaining 31 hedge fund holders during the fourth quarter of 2025.
Exact Sciences Corp (EXAS)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | ||
| 3. | 0 | $0 | 0% | ||
| 4. | 0 | $0 | 0% | ||
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $51.35 | 19,500 | $1,001,325.00 | 1,074,191 | 2024-11-13 | Filing | |
| $37.71 | 2,500 | $94,275.00 | 60,858 | 2017-08-17 | Filing | |
| $13.84 | 10,000 | $138,400.00 | 136,379 | 2016-12-14 | Filing | |
| $18.10 | 5,000 | $90,500.00 | 121,247 | 2016-09-01 | Filing | |
| $17.93 | 3,380 | $60,613.20 | 105,927 | 2016-08-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $75.00 | 5,000 | $375,000.00 | 23,237 | 2025-11-19 | Filing | |
| $70.00 | 1,000 | $70,000.00 | 11,585 | 2025-11-19 | Filing | |
| $70.08 | 1,500 | $105,120.00 | 12,585 | 2025-11-04 | Filing | |
| $70.08 | 2,858 | $200,288.64 | 22,368 | 2025-11-04 | Filing | |
| $65.00 | 12,000 | $780,000.00 | 60,759 | 2025-10-24 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,481 | $1,204,468 | 0% | |
| 2. | 10,479 | $1,064,247 | 0.1% | |
| 3. | 2,699 | $283,152 | 0.02% | |
| 4. | 1,655 | $173,626 | 0% | |
| 5. | 4,000 | $4,211 | 0% |
News See All
15 Stocks with the Biggest Hedge Fund Momentum
On February 23, Bloomberg News reported that during the week ended February 19, hedge funds registered record-high net sales of global stocks, the highest since early April 2025.
Multiple Tailwinds Lifted Exact Sciences Corporation (EXAS) in 2025
Baron Funds, an investment management company, released its “Baron Discovery Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Exact Sciences Corp. (EXAS) Rose Following the Acquisition Announcement
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” fourth-quarter 2025 investor letter. A copy of the same can be downloaded here. U.S.
Exact Sciences (EXAS) Rose Following the Acquisition Announcement by Abbott
Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Exact Sciences (EXAS) Climbs to 2-Year High on Abbot Merger Reports
Exact Sciences climbed to a new two-year high on Wednesday, as investors loaded portfolios following reports that it set to be taken over by Abbott Laboratories in what could be its largest acquisition...
Exact Sciences Corporation (NASDAQ:EXAS) Q3 2025 Earnings Call Transcript
Derek Leckow: Thank you for joining us for Exact Sciences' Third Quarter 2025 Conference Call today, November 3, 2025.
Exact Sciences, Healthmine Partner to Boost Cologuard Screening Rates via Health Plan Incentives
Exact Sciences Corporation (NASDAQ:EXAS) is one of the most promising long-term stocks to buy.
12 Most Promising Long-Term Stocks to Buy
On September 12, Abby Joseph Cohen, Columbia Business School professor and former Goldman Sachs partner & chief US strategist, joined 'Squawk Box' on CNBC to discuss the latest market trends, state of...
Jefferies Reiterates a Buy Rating on Exact Sciences Corporation (EXAS)
Exact Sciences Corporation (NASDAQ:EXAS) is one of the best strong buy growth stocks to buy now.